Joint Formulary & PAD

Pegvisomant - Acromegaly

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Not Specified
Associated Icons :
BNF SPC
NFD1
NHSE
Restrictions / Comments :
Important

For acromegaly: Commissied by NHSE from specialist centres only. Not provided by Surrey Heartlands Trusts

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Pegvisomant
Indication :
Acromegaly
Group Name :
Keywords :
Brand Names Include :
Somavert
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Pegvisomant is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Acromegaly.

Committee Recommendations (0)

  • No records returned.